| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.29▲ | 7.21▲ | 7.16▲ | 7.46▼ | 8.03▼ |
| MA10 | 7.25▲ | 7.12▲ | 7.21▲ | 7.83▼ | 8.69▼ |
| MA20 | 7.12▲ | 7.21▲ | 7.33▲ | 8.13▼ | 4.55▲ |
| MA50 | 7.09▲ | 7.48▼ | 7.62▼ | 7.64▼ | 2.34▲ |
| MA100 | 7.30▲ | 7.77▼ | 8.15▼ | 4.03▲ | 1.74▲ |
| MA200 | 7.52▼ | 8.15▼ | 8.43▼ | 2.31▲ | 1.73▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.031▲ | 0.044▲ | 0.013▲ | -0.216▼ | 0.243▲ |
| RSI | 73.802▲ | 53.883▲ | 48.326▼ | 40.764▼ | 63.402▲ |
| STOCH | 93.177▲ | 77.477 | 43.311 | 8.662▼ | 54.767 |
| WILL %R | 0.000▲ | -26.531 | -26.531 | -78.137▼ | -43.771 |
| CCI | 103.092▲ | 107.045▲ | 14.887 | -122.538▼ | 22.424 |
| CDL | $OTLK Hammer Candlestick Pattern Detected | Set Alert |
|
Thursday, May 16, 2024 09:00 AM
ISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of ...
|
|
Thursday, May 16, 2024 02:02 AM
Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA (bevacizumab gamma)United Kingdom (UK) Marketing Autho ...
|
|
Wednesday, May 15, 2024 11:53 PM
OTLK stock results show that Outlook Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/05/24 | 7.29 | 7.36 | 6.82 | 7.36 | 399,128 |
| 15/05/24 | 7.46 | 7.57 | 7.345 | 7.43 | 313,004 |
| 14/05/24 | 7.62 | 7.82 | 7.29 | 7.40 | 225,534 |
| 13/05/24 | 7.73 | 8.115 | 7.51 | 7.51 | 352,382 |
| 10/05/24 | 7.75 | 7.825 | 7.5253 | 7.58 | 392,664 |
| 09/05/24 | 8.18 | 8.18 | 7.6016 | 7.73 | 223,914 |
| 08/05/24 | 8.20 | 8.26 | 7.81 | 8.00 | 455,100 |
| 07/05/24 | 8.61 | 8.76 | 8.17 | 8.21 | 200,305 |
| 06/05/24 | 8.91 | 8.91 | 8.4501 | 8.50 | 241,264 |
| 03/05/24 | 8.57 | 8.88 | 8.515 | 8.60 | 101,290 |
|
|
||||
|
|
||||
|
|